Skip to main content
$24.62 $0.25 (1.0%)

04:30 PM EDT on 08/12/20

Revance Therapeutics, Inc. (NASDAQ:RVNC)

CAPS Rating: 2 out of 5

Current Price $24.62 Mkt Cap $1.6B
Open $24.64 P/E Ratio 0.00
Prev. Close $24.62 Div. (Yield) $0.00 (0.0%)
Daily Range $24.31 - $24.92 Volume 218,657
52-Wk Range $9.88 - $27.97 Avg. Daily Vol. 524,123

Caps

How do you think NASDAQ:RVNC will perform against the market?

Add Stock to CAPS Watchlist

All Players

22 Outperform
1 Underperform
 

All-Star Players

6 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:RVNC Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Exanut (49.36)
Submitted November 30, 2014

I am a physician in Canada. I perform Botox injections as part of my practice. Every patient that I see seems to want Botox, but the fear of injection is the biggest barrier to them getting it, rather than price. That said, I have patients in their… More

TSIF (99.99)
Submitted April 25, 2014

Revance Therapeutics, Inc is a little followed recent IPO (Feb 6) that had a good opening (from $21 issued to $27. Low volume, low float, round tripped up to $37 and decayed back to $27 (25%) on news it's phase 1/2 study of RT002 to reduce frown… More

NASDAQ:RVNC VS S&P 500 (SPY)

NASDAQ:RVNC Summary

Fools bullish on NASDAQ:RVNC are also bullish on:

Fools bearish on NASDAQ:RVNC are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about RVNC.

Recs

0
Member Avatar CMFBLSH (91.12) Submitted: 10/24/2017 5:42:45 PM : Outperform Start Price: $15.75 NASDAQ:RVNC Score: -2.68

Mechanism of action well understood in cosmetic applications from Phase II. Read out of Phase III data expected by end of year; Expect positive results, good safety profile and longer duration (than AGN's BoTox).

Recs

0
Member Avatar usubanas (99.63) Submitted: 1/12/2016 3:26:46 PM : Outperform Start Price: $25.83 NASDAQ:RVNC Score: -79.46

Botox competitor. Lots of catalysts in 2016

Recs

3
Member Avatar Exanut (49.36) Submitted: 11/29/2014 11:00:29 PM : Outperform Start Price: $16.40 NASDAQ:RVNC Score: -13.95

I am a physician in Canada. I perform Botox injections as part of my practice. Every patient that I see seems to want Botox, but the fear of injection is the biggest barrier to them getting it, rather than price. That said, I have patients in their 20s to their 70s who do receive Botox injections. I have to say, that I am always nervous injecting a toxin into the skin that can potentially kill my patient, especially since this is an elective procedure. If I had a non-injectable form of Botox that I could simply apply on the skin rather than inject into it, I would stop offering my patients Botox brand injections immediately and start offering them the Revance product instead. I am certain that I would be able to recruit more patients with this product, compared to the injection.

Leaderboard

Find the members with the highest scoring picks in RVNC.

Score Leader

skyrocket29

skyrocket29 (64.28) Score: +121.09

The Score Leader is the player with the highest score across all their picks in RVNC.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
drnetopsgolf 60.76 11/7/2019 Outperform 5Y $15.42 +58.55% +9.23% +49.32 0 Comment
BesV 28.62 1/13/2020 Outperform 3M $20.96 +16.60% +2.71% +13.89 0 Comment
BioTech20 52.21 1/23/2020 Outperform 5Y $22.53 +8.48% +1.71% +6.77 0 Comment
CMFBLSH 91.12 9/16/2016 Outperform 5Y $15.75 +55.17% +57.85% -2.68 1 Comment
baselineace 23.97 7/20/2020 Outperform 3M $24.61 -0.69% +4.65% -5.34 0 Comment
Bigcaps19 85.34 1/23/2020 Underperform 5Y $22.53 +8.48% +1.71% -6.77 0 Comment
shonny2 < 20 1/8/2019 Outperform 5Y $19.97 +22.38% +31.82% -9.43 0 Comment
uaau < 20 11/21/2014 Outperform 5Y $16.41 +48.93% +62.00% -13.07 1 Comment
duff5569 69.35 12/1/2014 Outperform 5Y $16.40 +49.02% +62.97% -13.95 0 Comment
Exanut 49.36 12/1/2014 Outperform 5Y $16.40 +49.02% +62.97% -13.95 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for RVNC.